At Eli Lilly Headquarters: Marketing Big Pharma Profits at Risk to the Public
We visit the headquarters of Eli Lilly in downtown Indianapolis where the power of Big Pharma has carved out Indiana’s political landscape, supplied its lobbyists and operatives, and created an empire of profits by (reportedly) treating the symptoms, hiding the risk and harm, and insisting on the safety of products – like Thimerosal and Prozac …Read more »
Science of Profit, Corporate Takeover of Science, Wake Up America #2
Be My Friend – http://www.myspace.com/psychtruth Science of Profit, Corporate Takeover of Science, Wake Up America #2 What influence has corporations and big Pharma had on science and government regulations via the FDA, NIH and CDC? Big money and conflicts of interest have changed the face of science and health care in America. Science’s Worst Enemy: …Read more »
FDA Drugs and Personal Injury – Overview
Overview of FDA Drugs as defective products with attorney Marc Bern, pharmaceutical injury litigation expert and partner in the law firm Napoli, Bern and Associates in New York, NY. Produced by InjuryBoard.com
CER low impact; Big Data In-patient MR; FDA continuing Mini-Sentinel? (PRVR 7/28-31/2014)
This week on Pharma Research VIDEO Report: 1) Experts agree the promise of comparative effectiveness research is having very little impact on healthcare decision making. 2) Dr. David Bates researched Big Data algorithms that he says can positively impact the expenditures on low-hanging fruit with in-patients. 3) The FDA must make a decision on whether …Read more »
In Business- “U.S.FDA Wants To Partner With Indian Regulators”
The U.S. FDA Commissioner Margaret Hamburg is busy meeting government officials and industry associations in India. On top of the agenda has been to ensure better co-operation between regulators in the two countries and improving quality of food and drugs being exported from India to the U.S.A. Watch as Bloomberg TV India speaks to Daara …Read more »